vs

Side-by-side financial comparison of DILLARD'S, INC. (DDS) and Marvell Technology, Inc. (MRVL). Click either name above to swap in a different company.

Marvell Technology, Inc. is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× DILLARD'S, INC.). Marvell Technology, Inc. runs the higher net margin — 91.7% vs 8.8%, a 82.8% gap on every dollar of revenue. On growth, Marvell Technology, Inc. posted the faster year-over-year revenue change (36.8% vs 2.9%). Marvell Technology, Inc. produced more free cash flow last quarter ($508.8M vs $156.2M). Over the past eight quarters, Marvell Technology, Inc.'s revenue compounded faster (20.6% CAGR vs -16.9%).

Dillard's, Inc. is an American department store chain founded in 1938 by William T. Dillard. It is headquartered in Little Rock, Arkansas, and operates approximately 272 stores in 30 states. Currently, the largest number of stores are located in Texas with 57 and Florida with 42.

Marvell Technology, Inc. is an American company, headquartered in Santa Clara, California, which develops and produces semiconductors and related technology. Founded in 1995, the company had more than 6,500 employees as of 2024, with over 10,000 patents worldwide, and an annual revenue of $5.5 billion for fiscal 2024.

DDS vs MRVL — Head-to-Head

Bigger by revenue
MRVL
MRVL
1.4× larger
MRVL
$2.1B
$1.5B
DDS
Growing faster (revenue YoY)
MRVL
MRVL
+33.9% gap
MRVL
36.8%
2.9%
DDS
Higher net margin
MRVL
MRVL
82.8% more per $
MRVL
91.7%
8.8%
DDS
More free cash flow
MRVL
MRVL
$352.6M more FCF
MRVL
$508.8M
$156.2M
DDS
Faster 2-yr revenue CAGR
MRVL
MRVL
Annualised
MRVL
20.6%
-16.9%
DDS

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
DDS
DDS
MRVL
MRVL
Revenue
$1.5B
$2.1B
Net Profit
$129.8M
$1.9B
Gross Margin
43.4%
51.6%
Operating Margin
11.5%
17.2%
Net Margin
8.8%
91.7%
Revenue YoY
2.9%
36.8%
Net Profit YoY
4.2%
381.1%
EPS (diluted)
$8.31
$2.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DDS
DDS
MRVL
MRVL
Q4 25
$1.5B
$2.1B
Q3 25
$1.5B
$2.0B
Q2 25
$1.5B
$1.9B
Q1 25
$2.0B
$1.8B
Q4 24
$1.4B
$1.5B
Q3 24
$1.5B
$1.3B
Q2 24
$1.5B
$1.2B
Q1 24
$2.1B
$1.4B
Net Profit
DDS
DDS
MRVL
MRVL
Q4 25
$129.8M
$1.9B
Q3 25
$72.8M
$194.8M
Q2 25
$163.8M
$177.9M
Q1 25
$214.4M
$200.2M
Q4 24
$124.6M
$-676.3M
Q3 24
$74.5M
$-193.3M
Q2 24
$180.0M
$-215.6M
Q1 24
$250.5M
$-392.7M
Gross Margin
DDS
DDS
MRVL
MRVL
Q4 25
43.4%
51.6%
Q3 25
36.6%
50.4%
Q2 25
43.9%
50.3%
Q1 25
34.9%
50.5%
Q4 24
42.6%
23.0%
Q3 24
37.6%
46.2%
Q2 24
44.6%
45.5%
Q1 24
36.6%
46.6%
Operating Margin
DDS
DDS
MRVL
MRVL
Q4 25
11.5%
17.2%
Q3 25
6.2%
14.5%
Q2 25
14.0%
14.3%
Q1 25
11.7%
12.9%
Q4 24
11.4%
-46.4%
Q3 24
6.5%
-7.9%
Q2 24
15.2%
-13.1%
Q1 24
13.3%
-2.3%
Net Margin
DDS
DDS
MRVL
MRVL
Q4 25
8.8%
91.7%
Q3 25
4.8%
9.7%
Q2 25
10.7%
9.4%
Q1 25
10.6%
11.0%
Q4 24
8.7%
-44.6%
Q3 24
5.0%
-15.2%
Q2 24
11.6%
-18.6%
Q1 24
11.8%
-27.5%
EPS (diluted)
DDS
DDS
MRVL
MRVL
Q4 25
$8.31
$2.20
Q3 25
$4.66
$0.22
Q2 25
$10.39
$0.20
Q1 25
$13.41
$0.23
Q4 24
$7.73
$-0.78
Q3 24
$4.59
$-0.22
Q2 24
$11.09
$-0.25
Q1 24
$15.41
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DDS
DDS
MRVL
MRVL
Cash + ST InvestmentsLiquidity on hand
$1.1B
$2.7B
Total DebtLower is stronger
$4.5B
Stockholders' EquityBook value
$2.0B
$14.1B
Total Assets
$4.3B
$21.6B
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DDS
DDS
MRVL
MRVL
Q4 25
$1.1B
$2.7B
Q3 25
$1.0B
$1.2B
Q2 25
$900.5M
$885.9M
Q1 25
$717.9M
$948.3M
Q4 24
$980.4M
$868.1M
Q3 24
$946.7M
$808.7M
Q2 24
$817.8M
$847.7M
Q1 24
$808.3M
$950.8M
Total Debt
DDS
DDS
MRVL
MRVL
Q4 25
$4.5B
Q3 25
$4.5B
Q2 25
$4.2B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.1B
Q1 24
$4.2B
Stockholders' Equity
DDS
DDS
MRVL
MRVL
Q4 25
$2.0B
$14.1B
Q3 25
$1.9B
$13.4B
Q2 25
$1.9B
$13.3B
Q1 25
$1.8B
$13.4B
Q4 24
$2.0B
$13.4B
Q3 24
$1.9B
$14.2B
Q2 24
$1.9B
$14.5B
Q1 24
$1.7B
$14.8B
Total Assets
DDS
DDS
MRVL
MRVL
Q4 25
$4.3B
$21.6B
Q3 25
$3.7B
$20.6B
Q2 25
$3.9B
$20.0B
Q1 25
$3.5B
$20.2B
Q4 24
$4.1B
$19.7B
Q3 24
$3.7B
$20.3B
Q2 24
$3.9B
$20.5B
Q1 24
$3.4B
$21.2B
Debt / Equity
DDS
DDS
MRVL
MRVL
Q4 25
0.32×
Q3 25
0.33×
Q2 25
0.32×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.29×
Q2 24
0.29×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DDS
DDS
MRVL
MRVL
Operating Cash FlowLast quarter
$186.5M
$582.3M
Free Cash FlowOCF − Capex
$156.2M
$508.8M
FCF MarginFCF / Revenue
10.6%
24.5%
Capex IntensityCapex / Revenue
2.1%
3.5%
Cash ConversionOCF / Net Profit
1.44×
0.31×
TTM Free Cash FlowTrailing 4 quarters
$781.3M
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DDS
DDS
MRVL
MRVL
Q4 25
$186.5M
$582.3M
Q3 25
$86.8M
$461.6M
Q2 25
$232.6M
$332.9M
Q1 25
$364.7M
$514.0M
Q4 24
$173.5M
$536.3M
Q3 24
$-68.4M
$306.4M
Q2 24
$244.4M
$324.5M
Q1 24
$436.5M
$546.6M
Free Cash Flow
DDS
DDS
MRVL
MRVL
Q4 25
$156.2M
$508.8M
Q3 25
$60.1M
$414.1M
Q2 25
$215.8M
$214.1M
Q1 25
$349.3M
$444.1M
Q4 24
$145.4M
$461.3M
Q3 24
$-94.3M
$258.2M
Q2 24
$209.2M
$233.0M
Q1 24
$408.2M
$475.6M
FCF Margin
DDS
DDS
MRVL
MRVL
Q4 25
10.6%
24.5%
Q3 25
4.0%
20.6%
Q2 25
14.1%
11.3%
Q1 25
17.3%
24.4%
Q4 24
10.2%
30.4%
Q3 24
-6.3%
20.3%
Q2 24
13.5%
20.1%
Q1 24
19.2%
33.3%
Capex Intensity
DDS
DDS
MRVL
MRVL
Q4 25
2.1%
3.5%
Q3 25
1.8%
2.4%
Q2 25
1.1%
6.3%
Q1 25
0.8%
3.8%
Q4 24
2.0%
4.9%
Q3 24
1.7%
3.8%
Q2 24
2.3%
7.9%
Q1 24
1.3%
5.0%
Cash Conversion
DDS
DDS
MRVL
MRVL
Q4 25
1.44×
0.31×
Q3 25
1.19×
2.37×
Q2 25
1.42×
1.87×
Q1 25
1.70×
2.57×
Q4 24
1.39×
Q3 24
-0.92×
Q2 24
1.36×
Q1 24
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons